If a major Wall Street broker-dealer publishes a research report delivering a glowing "strong buy" recommendation on a high-profile stock, that report has the power to move market prices.
Imagine the temptation: what if the firm’s trading desk secretly loaded up on millions of shares today, issued the glowing report tomorrow morning, and then dumped those shares onto eager retail customers at inflated prices?
To protect investors and maintain fair markets, regulators draw a hard line against this practice. Under FINRA rules, a research report is defined as any written or electronic communication that includes an analysis of equity securities of individual companies or industries, providing information reasonably sufficient upon which to base an investment decision.
Because these reports carry immense market weight, regulators enforce strict rules governing how research is prepared, insulated, and published.
1. The Prohibition Against "Trading Ahead" of Research Reports
When a firm purposefully adjusts its inventory position in a security, whether listed on NASDAQ, an exchange, the OTC market, or a related derivative, in anticipation of issuing a research report, it is engaging in a practice known as trading ahead.
FINRA explicitly bans firms from accumulating shares prior to publishing a recommendation to fill expected customer demand from firm inventory. Regulators deem this conduct completely inconsistent with just and equitable principles of trade. A member firm cannot purposefully establish, create, or alter its inventory position in anticipation of its own research department releasing a report.
2. Erecting a Chinese Wall Between Research and Investment Banking
Historically, research analysts often acted as cheerleaders for public companies, writing flattering coverage to help their firm win lucrative investment banking business—such as underwriting stock offerings or advising on mergers.
To eliminate this fundamental conflict of interest, FINRA regulations mandate a total operational separation between research departments and investment banking teams:
- No Supervisory Control: Research analysts cannot be supervised, managed, or controlled by any employee of the firm's investment banking department.
- Separation of Compensation: Investment banking personnel are barred from having any influence or control over an analyst's compensation, performance evaluations, or bonuses. Furthermore, analysts cannot receive any salary or bonus tied to a specific investment banking transaction.
- No Pitch Participation: Analysts are strictly prohibited from participating in efforts to solicit investment banking deals. They cannot join "pitches" to prospective investment banking clients, conduct communications to drum up underwriting business, or participate in promotional IPO "roadshows."
3. Strict Personal Trading Restrictions for Analysts
The rules prohibiting market manipulation extend directly to the personal brokerage accounts of research analysts and their immediate families:
- Pre-IPO Restrictions: Analysts cannot purchase or receive pre-IPO shares of any company principally engaged in the same line of business as companies the analyst follows.
- The 30-Day / 5-Day Blackout Window: An analyst cannot buy or sell any security issued by a company they cover, or any option or derivative of that security—during a blackout period starting 30 calendar days before and ending 5 calendar days after the publication of a research report or a change in rating/price target.
- Coverage Initiation Exception: A firm may permit an analyst to sell pre-existing holdings in a covered company within 30 calendar days after the analyst initially begins covering that company for the firm.
4. Guarding Pre-Publication Drafts and Information Leaks
Allowing non-research colleagues or executive management to preview a research report before publication creates immediate risk of tipping or insider trading. FINRA enforces strict protocols surrounding pre-publication reviews:
Internal Non-Research Reviews
Non-research personnel (such as trading or management staff) may only review a draft to verify factual accuracy or identify potential conflicts of interest. All written communication regarding the draft must go through - or be copied to - authorized Legal or Compliance personnel. All oral discussions must be conducted in the presence of, or through, Legal or Compliance staff.
Submitting Drafts to Subject Companies
A broker-dealer may submit sections of a draft report to the target company being covered solely to verify factual accuracy, provided strict conditions are met:
- The draft sections sent to the target company must never include the research summary, the rating, or the price target.
- A complete copy of the draft must be provided to Legal or Compliance personnel before any section is shared with the target company.
- If the research department decides to alter its proposed rating or price target after factual review, it must submit written justification to Legal or Compliance and receive formal written authorization before making the change.
- All draft versions and final reports must be retained by the firm for 3 years following publication.
Notifying Companies of Rating Changes: A firm may inform a subject company that it intends to change its rating, but only on the business day prior to the public announcement, and strictly after the close of trading in the primary market for that security.
5. Quiet Periods, Third-Party Research, and Regulation AC
To further ensure research integrity and transparency, regulatory frameworks enforce three additional safeguard rules:
- The 10-Day IPO Quiet Period: Following an Initial Public Offering (IPO), member firms involved in the underwriting cannot publish research reports on the newly public company for a "quiet period" of 10 calendar days.
- Third-Party Research Disclosures: Smaller broker-dealers that do not employ in-house analysts often distribute research prepared by independent third parties. When delivering third-party reports to clients, the firm must explicitly disclose that the research was produced by an outside entity.
- SEC Regulation AC (Analyst Certification): Regulation AC requires analysts to formally certify that the views expressed in their research reports and public appearances accurately reflect their personal, objective opinions. Analysts must explicitly disclose whether they or their immediate family members received any cash or non-cash compensation tied to their specific recommendations.